Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Oncol. 2016 May 20;34(15):e141-4. doi: 10.1200/JCO.2013.50.5016. Epub 2014 Nov 3.

Effect of the RET Inhibitor Vandetanib in a Patient With RET Fusion-Positive Metastatic Non-Small-Cell Lung Cancer.

Author information

  • 1The University of Texas MD Anderson Cancer Center, Houston, TX Gerald.Falchook@scresearch.net.
  • 2The University of Texas MD Anderson Cancer Center, Houston, TX.
  • 3Foundation Medicine, Cambridge, MA.
PMID:
25366691
DOI:
10.1200/JCO.2013.50.5016
[PubMed - in process]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center